BENITEC BIOPHARMA INC
BNTC·08205P209·US·Common Stock·Healthcare - Biotechnology-Activist
BNTC (BENITEC BIOPHARMA INC) is held by 58 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($30.7M), FRANKLIN RESOURCES INC ($25.3M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($22.6M). Net institutional sentiment: Bullish.
58
Holders
Avg rating(11 Elite)
$173.6M
Total Value
80% (62)
Fund Consensus
44 buying - 11 selling
Who's Trading
InsiderSLSUVRETTA CAPITAL MANAGEMENT, LLCBuy $884KDec 29, 2025
InsiderSLSUVRETTA CAPITAL MANAGEMENT, LLCBuy $156KDec 29, 2025
InsiderSLSUVRETTA CAPITAL MANAGEMENT, LLCBuy $188KDec 26, 2025
InsiderSLSUVRETTA CAPITAL MANAGEMENT, LLCBuy $33KDec 26, 2025
InsiderSLSUVRETTA CAPITAL MANAGEMENT, LLCBuy $547KDec 23, 2025
InsiderSLSUVRETTA CAPITAL MANAGEMENT, LLCBuy $95KDec 23, 2025
InsiderSLSUVRETTA CAPITAL MANAGEMENT, LLCBuy $201KDec 22, 2025
InsiderSLSUVRETTA CAPITAL MANAGEMENT, LLCBuy $35KDec 22, 2025
13F: Insider & Congress:
Showing 1-20 of 62
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer